Delcath Systems DCTH Foreign — Product revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Delcath Systems in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Delcath Systems's foreign — product revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Delcath Systems's foreign — product revenue?
- Delcath Systems (DCTH) reported foreign — product revenue of $1.75M in Q1 2026.
- How has Delcath Systems's foreign — product revenue changed year-over-year?
- Delcath Systems's foreign — product revenue decreased by 0.8% year-over-year, from $1.76M to $1.75M.
- What does foreign — product revenue mean?
- This metric represents the total gross sales generated from the sale of pharmaceutical products and associated medical delivery systems within international markets outside of the company's primary domestic region. It serves as a key indicator of the company's global commercial expansion and the adoption rate of its specialized oncology therapies in foreign healthcare systems. Monitoring this figure helps investors assess the effectiveness of international distribution strategies and the scalability of the product portfolio across diverse regulatory environments.